Total Funding
63
34
Total FundingGrant raised
Growth Score 63 in past quarter
-4 pts
Heat Score 34 in past quarter
-16 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
156379
LamdaGen is a developer of nano-based plasmonic biosensors and robust diagnostic systems.
- Daniele Gerion: Chief Technology Officer
- Randy Storer: CEO and Founder
About the Company
LamdaGen is a developer of nano-based plasmonic biosensors and robust diagnostic systems. The company is increasing access to healthcare with its L’AuRa diagnostic platform, a game-changing technology. L’AuRa is an immuno-based platform that combines the high sensitivity and precision of ELISA with the simplicity and speed of lateral flow to enable
quantitative and rapid detection of diseases, pathogens and contaminants. LamdaGen licenses its L’AuRa technology to companies in the human diagnostic, companion animal and food safety industries.